-+ 0.00%
-+ 0.00%
-+ 0.00%

Trulieve highlights 2025 revenue of $1.2 billion in investor presentation

PUBT·09/02/2026 12:12:17
Listen to the news
Trulieve highlights 2025 revenue of $1.2 billion in investor presentation
  • Trulieve investor presentation highlighted NYSE listing under ticker TRLV, following medical marijuana rescheduling to Schedule III.
  • Corporate restructuring deconsolidated Harvest mixed-use operations to support the NYSE listing; Trulieve retained 90% economic interest.
  • Consolidated business positioned as DEA-registered, state-licensed medical-only operations with 207 dispensaries and 3.5 million sq. ft. capacity.
  • Harvest platform described as independently controlled, spanning Arizona, Connecticut, Maryland, Ohio with 34 dispensaries and 0.5 million sq. ft. capacity.
  • 2025 results cited USD 1.2 billion revenue, 60% gross margin, USD 273 million operating cash flow; Florida, Pennsylvania flagged as cash drivers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trulieve Cannabis Corp. published the original content used to generate this news brief on September 02, 2026, and is solely responsible for the information contained therein.